Navigation Links
Immucor Announces Fiscal Third Quarter Results
Date:4/6/2009

pril 7, 2009 at 8:30 AM (Eastern Time) to review these results. Investors are invited to participate in this conference call with Dr. Gioacchino De Chirico, President and Chief Executive Officer; Richard A. Flynt, Chief Financial Officer; and Edward L. Gallup, consultant.

To participate in the telephone conference call, dial 1-888-324-7567 (Passcode: BLUD). The Company will also provide a live audio broadcast of the call via webcast. The webcast can be accessed at www.immucor.com in the "About Us - Investor Information" section by selecting the webcast link. For those unable to listen to the live broadcast of the call, a replay will be available shortly after completion of the call and will be archived on Immucor's website for approximately 60 days. Additionally, a replay of the call will be available for one week beginning at 12:00 PM on April 7, 2009 by calling 1-866-373-9229 (Passcode: 2583).

About Immucor

Founded in 1982, Immucor manufactures and sells a complete line of reagents and systems used by hospitals, reference laboratories and donor centers to detect and identify certain properties of the cell and serum components of blood prior to transfusion. Immucor markets a complete family of automated instrumentation for all of its market segments. For more information on Immucor, please visit our website at www.immucor.com.

Safe Harbor Statement

This press release contains statements that are "forward-looking statements" as that term is defined under federal securities laws. Forward-looking statements contained in this press release include the intent, belief or current expectations of the Company and members of its management team with respect to the Company's future business operations as well as the assumptions upon which such statements are based. Forwar
'/>"/>

SOURCE Immucor, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Immucor Announces New Vice President, Operations
2. Immucor Announces Fiscal Second Quarter Results; Raises Fiscal 2009 EPS Guidance
3. Immucor Closes BioArray Acquisition
4. Immucor Schedules Fiscal 2009 Guidance Call
5. Immucor Responding to FDA Warning Letter
6. Immucor Announces Record Fiscal Third Quarter Results
7. Immucor Schedules Third Quarter Earnings Release and Conference Call
8. Immucor, Inc. Adds Director to Board
9. Immucor Announces Update to Second Quarter Conference Call Number
10. Immucor, Inc. Appoints New Chief Financial Officer
11. Immucor Announces Record Fiscal First Quarter Revenues
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/1/2015)... 01, 2015 Tempaper has joined forces ... virtual giving campaign that will raise critical funds to ... muscle disease across the United States. , Throughout the ... Tempaperdesigns.com will automatically receive free domestic ground ... and urgently needed progress to children and adults affected ...
(Date:4/1/2015)... FL (PRWEB) April 01, 2015 IQ ... growing health and nutritional supplement companies in the U.S., today ... the testing and quality control standards for its herbal supplements.* ... the supply chain to ensure the accuracy of labeling on ... industry veteran and IQ Formulations CEO Jay Cohen ...
(Date:4/1/2015)... April 01, 2015 When annoying or ... waiting days or weeks for an appointment with a ... and next day appointments haven’t been possible within dermatology. ... Dermatology’s offices have noticed demand for this level of ... realize how important relief or answers to dermatological issues ...
(Date:4/1/2015)... The 2015 Deep Market Research ... professional and in-depth study on the current state ... with a focus on the Chinese situation. , ... are Pfizer, Lek Pharmaceuticals D.D., Dr Reddys Labs ... Limited, Cadila Healthcare Limited, Sandoz Inc, Teva Pharms, ...
(Date:4/1/2015)... New York, NY (PRWEB) April 01, 2015 ... currently reports there are “more than 123,000 patients who ... may not be aware of this surprising statistic. ... to Donate Life” PSA, Erik Compton, a PGA TOUR ... organ donation and encourages Americans to become organ donors. ...
Breaking Medicine News(10 mins):Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 2Health News:Tempaper and MDA Team up in the Fight Against Muscle Disease 3Health News:IQ Formulations Applauds GNC for Enhancing Its Testing and Quality Control Processes for Herbal Supplements 2Health News:Dermatology Associates of Wisconsin and Forefront Dermatology Answers Patients' Needs With Unmatched Availability In Sheboygan and Sheboygan Falls 2Health News:Atorvastatin Calcium Industry International & China Market Analysis 2015-2020 2Health News:Atorvastatin Calcium Industry International & China Market Analysis 2015-2020 3Health News:Donate Life America and Genentech have Partnered to Develop the “Play Through with Erik Compton to Donate Life" Public Service Announcement 2
... both brain development and GI system functions, study finds ... identified a gene variant that is associated with both ... The finding may represent early identification of a sub-type ... another group who have autism and don,t have gastrointestinal ...
... Supply Chain Systems, and Amerinet Also Extend Existing ... /PRNewswire-FirstCall/ -- Masimo (Nasdaq: ... Measure-Through Motion and Low-Perfusion pulse oximetry, announced today ... Purchasing Organizations (GPOs) have established a new Pulse ...
... Kansas Governor A Leader in Fight for Quality ... General President Jim Hoffa issued the following statement ... nominating Kansas Gov. Kathleen Sebelius as Secretary of ... President Obama nominated Gov. Sebelius as HHS Secretary."Candidate ...
... of the PAM™ Assessment in Chronic Disease Coaching , ... ... its commitment to implement the latest advances in behavior change, ... in the country to introduce a powerful health activation tool for ...
... Detector Designed for Ultra-High Performance Liquid Chromatography (UHPLC) ... Cell CHELMSFORD, Mass., March 2 ESA Biosciences, ... novel HPLC systems that improve results for pharmaceutical ... worldwide, will launch a new, ultra-high-performance version of ...
... in rich societies the poor have shorter lives and ... inequalities of income are often regarded as divisive and ... years, research, Richard Wilkinson, Emeritus Professor at The University ... University of York, go an important stage beyond either ...
Cached Medicine News:Health News:Gene Variant Allies Autism, Gastrointestinal Woes 2Health News:Gene Variant Allies Autism, Gastrointestinal Woes 3Health News:Three Healthcare GPOs to Offer Masimo Rainbow SET(R) Pulse CO-Oximetry(TM) to Their Members 2Health News:Three Healthcare GPOs to Offer Masimo Rainbow SET(R) Pulse CO-Oximetry(TM) to Their Members 3Health News:Three Healthcare GPOs to Offer Masimo Rainbow SET(R) Pulse CO-Oximetry(TM) to Their Members 4Health News:Three Healthcare GPOs to Offer Masimo Rainbow SET(R) Pulse CO-Oximetry(TM) to Their Members 5Health News:Hoffa Praises Sebelius Pick for HHS Secretary 2Health News:LifeMasters Introduces Health Activation Tool to Disease Management Participants 2Health News:LifeMasters Introduces Health Activation Tool to Disease Management Participants 3Health News:LifeMasters Introduces Health Activation Tool to Disease Management Participants 4Health News:ESA to Launch Corona(R) ultra(TM) at Pittcon 2009: Booth #1080 2Health News:ESA to Launch Corona(R) ultra(TM) at Pittcon 2009: Booth #1080 3Health News:ESA to Launch Corona(R) ultra(TM) at Pittcon 2009: Booth #1080 4Health News:ESA to Launch Corona(R) ultra(TM) at Pittcon 2009: Booth #1080 5Health News:Material success and social failure? 2
(Date:4/1/2015)... 2015 LifeScienceIndustryResearch.com announces ... Industry and 2015 Deep Research Report on ... Pharmaceutical category in its database.  ... basic information, including definition, classification, application, industry ... news analysis, etc. Azithromycin Key Manufacturers Analysis ...
(Date:4/1/2015)... -- Jintian Pharmaceutical Group Limited ("Jintian Pharmaceutical" or the ... chairman and executive director purchased 40,000,000 ordinary shares (the ... entire issued share capital of the Company from AMG ... amount of approximately HK$113 million. Upon the completion of ... 45.17% to 47.17%. Mr. Jin Dongtao, ...
(Date:4/1/2015)... and Markets ( http://www.researchandmarkets.com/research/n9mxqs/an_introduction ) has announced ... Medical Device Directives" conference to their offering. ... European medical device legislation. It will explain the Directives ... Bodies, how to choose one and outline what a ... necessary to apply for the CE mark. ...
Breaking Medicine Technology:Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 2Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 3Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 4Azithromycin Market & Polypeptide Drug Industry - Global Research Reports 5Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 2Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 3Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 4Chairman of Jintian Pharmaceutical Purchased Approximately HK$113 Million Worth of Shares Citing Confidence in Company's Development in Online and Offline MacroHealth Business 5An Introduction to the Medical Device Directives Training: London, UK - 13th, 14th, 15th of May 2015 2
... Labs, Inc. (OTCQB/OTCBB: GOVX), an Atlanta-based biopharmaceutical firm developing ... infections, announced today the completion of enrollment for a ... vaccine is being developed for use in uninfected people ... virus. The trial, designated HVTN 205, is being conducted ...
... Inc. (NASDAQ: VVUS ) today announced that ... th Annual Scientific Meeting of The Obesity Society ... long-term beneficial effects of Qnexa ® treatment in ... significant improvement in liver function and reductions in medications ...
Cached Medicine Technology:GeoVax Phase 2a Clinical Trial Completes Enrollment 2GeoVax Phase 2a Clinical Trial Completes Enrollment 3GeoVax Phase 2a Clinical Trial Completes Enrollment 4Two-year Treatment With Qnexa Has Benefits Beyond Weight Loss 2Two-year Treatment With Qnexa Has Benefits Beyond Weight Loss 3Two-year Treatment With Qnexa Has Benefits Beyond Weight Loss 4Two-year Treatment With Qnexa Has Benefits Beyond Weight Loss 5Two-year Treatment With Qnexa Has Benefits Beyond Weight Loss 6
ZYMAR™ ophthalmic solution is an anti-infective prescription eye drop that your doctor may instruct you to use if you have an eye infection caused by bacteria. Bacterial conjunctivitis is the e...
... P.M.® lets you sleep on ... in the morning awake with ... ready to take on the ... comfort and protection, this preservative-free ...
Due to its thick formula, REFRESH CELLUVISC Lubricant Eye Drops is ideal for persistent dry eye conditions. REFRESH CELLUVISC provides lasting relief and protection for dry, scratchy eyes....
ALPHAGAN® (brimonidine tartrate ophthalmic solution) 0.2% is indicated for lowering IOP in patients with open-angle galucoma or ocular hypertension....
Medicine Products: